Harren Jhoti

Harren Jhoti
Born1962 (age 61–62)[1]
Alma mater
Known forAstex Pharmaceuticals
AwardsUK BioIndustry Association (BIA) Lifetime Achievement Award (2018)
European Federation for Medicinal Chemistry Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery (2012)
Royal Society of Chemistry Entrepreneur of the Year (2007)
Scientific career
FieldsDrug discovery
Structural biology
InstitutionsAstex

GlaxoWellcome

University of Oxford
Thesis X-ray structural studies on transferrins (1989)
Websiteastx.com/portfolio-item/harren-jhoti/

Harren Jhoti (born 1962[1]) is an Indian-born British structural biologist whose main interest has been rational drug design and discovery.[3][4] He is president and chief executive officer (CEO) of biotechnology company Astex Pharmaceuticals ("Astex") which is located in Cambridge, United Kingdom.

  1. ^ a b c Anon (2016). "Jhoti, Dr Harren". Who's Who (online Oxford University Press ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.286522. (Subscription or UK public library membership required.)
  2. ^ Jhoti, Harren (1989). X-ray structural studies on transferrins. London.ac.uk (PhD thesis). University of London. OCLC 940322045. Copac 29529053.
  3. ^ Anon (2018). "Dr Harren Jhoti FRS". Royalsociety.org. London: Royal Society. Archived from the original on 2018-05-14. One or more of the preceding sentences incorporates text from the royalsociety.org website where:

    "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License." --"Terms, conditions and policies | Royal Society". Archived from the original on 2016-11-11. Retrieved 2018-05-23.{{cite web}}: CS1 maint: bot: original URL status unknown (link)

  4. ^ "Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery".